Prolonged progression free interval in a patient with locally recurrent small cell lung cancer presenting with cerebellar paraneoplastic syndrome

Dalia Kamel , Alexander Boag , Andrea Bezjak , Mihaela Mates
{"title":"Prolonged progression free interval in a patient with locally recurrent small cell lung cancer presenting with cerebellar paraneoplastic syndrome","authors":"Dalia Kamel ,&nbsp;Alexander Boag ,&nbsp;Andrea Bezjak ,&nbsp;Mihaela Mates","doi":"10.1016/j.ctrc.2015.08.005","DOIUrl":null,"url":null,"abstract":"<div><p>Small cell lung carcinoma (SCLC) accounts for 15–20% of all lung cancers and is the most aggressive lung-cancer subtype. Even with treatment median overall survival is short, in the range of 9–12 months. Tobacco smoking is the main risk factor with nearly 95% of the cases being linked to smoking. Historically SCLC was classified into two stages – limited stage, when disease is confined to one hemithorax that can be encompassed into one radical radiation field, and extensive stage beyond the former boundaries. Recently, the International Association of the Study of Lung Cancer has proposed using the TNM staging system for more accurate estimation of prognosis. Chemotherapy remains the cornerstone of SCLC management in both limited and extensive stages, in conjunction with radiotherapy. In this case report we are describing a SCLC patient with an unusual pattern of local recurrence and prolonged course of disease.</p></div>","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrc.2015.08.005","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213089615300104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Small cell lung carcinoma (SCLC) accounts for 15–20% of all lung cancers and is the most aggressive lung-cancer subtype. Even with treatment median overall survival is short, in the range of 9–12 months. Tobacco smoking is the main risk factor with nearly 95% of the cases being linked to smoking. Historically SCLC was classified into two stages – limited stage, when disease is confined to one hemithorax that can be encompassed into one radical radiation field, and extensive stage beyond the former boundaries. Recently, the International Association of the Study of Lung Cancer has proposed using the TNM staging system for more accurate estimation of prognosis. Chemotherapy remains the cornerstone of SCLC management in both limited and extensive stages, in conjunction with radiotherapy. In this case report we are describing a SCLC patient with an unusual pattern of local recurrence and prolonged course of disease.

以小脑副肿瘤综合征为表现的局部复发小细胞肺癌患者的无进展时间延长
小细胞肺癌(SCLC)占所有肺癌的15-20%,是最具侵袭性的肺癌亚型。即使接受治疗,中位总生存期也很短,在9-12个月之间。吸烟是主要的危险因素,近95%的病例与吸烟有关。从历史上看,SCLC被分为两个阶段:局限性阶段,当疾病局限于一个可以被包围到一个根治性放射场的半胸时,以及超出前者边界的广泛阶段。最近,国际肺癌研究协会提出使用TNM分期系统来更准确地估计预后。化疗仍然是SCLC治疗的基石,在有限和广泛的阶段,结合放疗。在这个病例报告中,我们描述了一个不寻常的局部复发模式和病程延长的SCLC患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信